Cardiac Insight raises $4.5M to scale production and sales of FDA-cleared Cardeo Solo seven-day wearable ECG

Cardiac Insight raised $4.5 million to expand production, distribution, sales, and marketing of its FDA-cleared Cardeo Solo disposable wearable ECG that adheres to skin for up to seven days and enables physicians to diagnose cardiac anomalies without in-office monitoring.

No comments yet.